Detalhe da pesquisa
1.
Phase I study of [131I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol.
BMC Cancer
; 22(1): 417, 2022 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35428211
2.
Effectiveness and safety of nivolumab in patients with advanced melanoma: A multicenter, observational study.
Int J Cancer
; 148(11): 2789-2798, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33428772
3.
Immune checkpoint inhibitors reverse tolerogenic mechanisms induced by melanoma targeted radionuclide therapy.
Cancer Immunol Immunother
; 69(10): 2075-2088, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32447411
4.
Vismodegib efficacy in unresectable trichoblastic carcinoma: A multicenter study of 16 cases.
J Am Acad Dermatol
; 86(6): 1365-1366, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34052337
5.
Eight Years' Experience of Sentinel Lymph Node Biopsy in Melanoma Using Lymphoscintigraphy and Gamma Probe Detection After Radiocolloid Mapping.
Dermatol Surg
; 43(2): 287-292, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27893540
6.
Tetraspanin8 expression predicts an increased metastatic risk and is associated with cancer-related death in human cutaneous melanoma.
Mol Cancer
; 20(1): 127, 2021 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34600553
7.
Sentinel node status and immunosuppression: recurrence factors in localized Merkel cell carcinoma.
Acta Derm Venereol
; 95(7): 835-40, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25784178
8.
Clostridium difficile infection and immune checkpoint inhibitor-induced colitis in melanoma: 18 cases and a review of the literature.
Melanoma Res
; 33(3): 192-198, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36995276
9.
Retrospective analysis of real-world data to evaluate actionability of a comprehensive molecular profiling panel in solid tumor tissue samples (REALM study).
PLoS One
; 18(9): e0291495, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37708140
10.
First-Line, Fixed-Duration Nivolumab Plus Ipilimumab Followed by Nivolumab in Clinically Diverse Patient Populations With Unresectable Stage III or IV Melanoma: CheckMate 401.
J Clin Oncol
; 41(23): 3917-3929, 2023 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37307514
11.
Pregnancy promotes melanoma metastasis through enhanced lymphangiogenesis.
Am J Pathol
; 178(4): 1870-80, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21435464
12.
Familial melanoma: clinical factors associated with germline CDKN2A mutations according to the number of patients affected by melanoma in a family.
J Am Acad Dermatol
; 67(6): 1257-64, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22841127
13.
Metastatic melanoma treated by immunotherapy: discovering prognostic markers from radiomics analysis of pretreatment CT with feature selection and classification.
Int J Comput Assist Radiol Surg
; 17(10): 1867-1877, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35650345
14.
An open label, non-randomised, phase IIIb study of trametinib in combination with dabrafenib in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: A subgroup analysis of patients with brain metastases.
Eur J Cancer
; 175: 254-262, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36170791
15.
Efficacy, safety and factors associated with disease progression in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: An open label, non-randomized, phase IIIb study of trametinib in combination with dabrafenib.
Eur J Cancer
; 154: 57-65, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34243078
16.
Positive Association Between Location of Melanoma, Ultraviolet Signature, Tumor Mutational Burden, and Response to Anti-PD-1 Therapy.
JCO Precis Oncol
; 52021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34950838
17.
Cemiplimab for Locally Advanced and Metastatic Cutaneous Squamous-Cell Carcinomas: Real-Life Experience from the French CAREPI Study Group.
Cancers (Basel)
; 13(14)2021 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34298764
18.
Association of Anti-Programmed Cell Death 1 Antibody Treatment With Risk of Recurrence of Toxic Effects After Immune-Related Adverse Events of Ipilimumab in Patients With Metastatic Melanoma.
JAMA Dermatol
; 156(9): 982-986, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32667663
19.
Phase II Study of Pembrolizumab As First-Line, Single-Drug Therapy for Patients With Unresectable Cutaneous Squamous Cell Carcinomas.
J Clin Oncol
; 38(26): 3051-3061, 2020 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32730186
20.
Neurological toxicities of targeted therapies in melanoma: a multicenter national observational study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée, GCC).
J Neurol
; 271(3): 1473-1482, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38052771